Catalyst Event
Pfizer Inc (PFE) · Other
From Akros U.S. Large Cap 500 Index (AUL500)
3/23/2026, 12:00:00 AM
Announced positive topline results from the Phase 3 trial of its Lyme disease vaccine candidate (PF-07307405), showing over 70% efficacy. Estimated price impact ≥1% due to clinical success expected.
Korean Translation
라임병 백신 후보물질(PF-07307405)의 3상 임상시험에서 70% 이상의 효능을 보인 긍정적인 탑라인 결과를 발표함. 임상 성공에 따른 1% 이상의 주가 영향이 예상됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
The company announced it will host its Financial Analyst Day on September 16, 2026, to provide updates on company strategy, growth initiatives, and its long-term financial plan. A low impact is estimated as such events typically provide incremental information. This event is scheduled.
9/16/2026, 12:00:00 AM
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Dell Technologies Inc (DELL) · Earnings Release
Dell Technologies Fiscal Year 2027 First Quarter results scheduled.
5/28/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Vertiv Holdings Co (VRT) · Other
Vertiv will host its 2026 Investor Conference from May 19-20, 2026, where management will provide updates on strategic initiatives and market trends, and this is expected to cause moderate price volatility, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM